About BioPhero
BioPhero is a Chemicals & Materials company based in Copenhagen (Denmark) founded in 2018 by Carina Holkenbrink. Insect pheromones for pest management are produced and supplied. It operates in the Chemicals & Materials and Agriculture sectors. BioPhero has raised $21.75 million across 6 funding rounds from investors including European Union, DCVC and Novo Holdings. The company has 14 employees. BioPhero was last valued at $21.4 million in February 2021. Its chief executive, as recorded, is Kristian Ebbensgaard. The company has since been acquired. Its focus areas include Chemicals and Materials Tech, Chemicals Tech, Green Chemicals and Crop Protection. Its legal entity is BioPhero ApS.
Company details
BioPhero was established in 2018 in Copenhagen, Denmark. Insect pheromones are manufactured via a fermentation process involving yeasts, targeting pest control in agriculture. Solutions are provided for specialty crops including apples and grapes. Operations focus on the biotechnology sector, with headquarters located in Lyngby, supporting sustainable pest management practices across Europe.
- Headquarters Copenhagen, Denmark
- Employees 14
- Founders Carina Holkenbrink
- Stage Acquired
- SectorsChemicals & MaterialsAgriculture
- Email••••••••
- Phone•••• ••••
- Website biophero.com
- Social LinkedIn X
- Legal Name Biophero Aps
- Net Profit-$1.39 M (USD)-92as on Dec 31, 2020
- Total Equity Funding$21.75M (USD)
in 6 rounds
- Latest Funding Round$17M (USD), Series A
Feb 2021
- InvestorsEuropean Union
& 5 more
- Employee Count14
Funding Insights of BioPhero
BioPhero has successfully raised a total of $21.75M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.75M
- Total Rounds 6
- Last Round Series A — $17M
- First Round $2.43M
(Jan 2018)
- Investors Count 6
All 6 funding rounds of BioPhero with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $17M | Series A | $21.4M | DCVC | |
| Dec 2019 | $1.1M | Seed | $7.25M | – | – |
| Apr 2019 | $245,747 | Grant | – | – | |
| Sep 2018 | $3M | Seed | – | Syddansk Innovation, Novo Holdings | – |
| Feb 2018 | $651,752 | Seed | $••••• | – | – |
| Jan 2018 | $2.43M | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2021 | $21.4M | •••••••• |
| Dec 2019 | $7.25M | •••••••• |
| Feb 2018 | $••••• | •••••••• |
Full valuation and stage history of BioPhero
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $21.4M (Feb 2021). 6 investors in total: 6 institutional.
Investors in BioPhero
BioPhero has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, DCVC and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
| fmcventures.tcc.mode | ||||
A platform for business and technology insights is operated. | syddanskinnovation.dk | Denmark | ||
Investments are directed toward agri-food sectors via fund of funds. | syngentagroupventures.com | Basel, Switzerland | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for BioPhero
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioPhero
443 people are tracked at BioPhero (116 in leadership, 12 in board & advisors, 315 in team); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Carina Holkenbrink | Co-Founder | Leadership |
Kristian Ebbensgaard | CEO | Leadership |
Ronaldo Pereira | EVP & President, FMC Americas | Leadership |
Seva Rostovtsev | VP & CTO | Leadership |
David A. Kotch | VP & Chief Information Officer | Leadership |
Brian Blair | VP, Treasurer | Leadership |
Hilary Eberle | Director, IT Strategy, Portfolio And Change Management | Leadership |
Thaisa Hugenneyer | VP, Procurement, Logistics & Global Facilities | Leadership |
Brian P. Angeli | VP Corporate Strategy & Development | Leadership |
Sara Velazquez Ponessa | Executive Vice President, General Counsel And Corporate Secretary | Leadership |
Mark A. Douglas | President & CEO | Leadership |
Andrew D. Sandifer | EVP & Chief Financial Officer | Leadership |
Barry J. Crawford | VP, Operations | Leadership |
Gustavo Bosio | Director Of External Affairs, Value Chain | Leadership |
Catherine Pang | Head Human Resources APG APAC | Leadership |
Nicholas L. Pfeiffer | VP, Corporate Controller & Chief Accounting Officer | Leadership |
Bill Chester | VP, Global Tax | Leadership |
Robert West | Associate Director Customer Engagement Center | Leadership |
Nabeel Sarwar | Head Of Indirect Procurement | Leadership |
Pooja Prabhakar | Business Head- General Trade, Institution & Household Segment | Leadership |
423 more people are available in the full profile.
Complete people profiles for BioPhero
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioPhero
4 dated milestones of BioPhero across 3 years, from founding to its latest funding, stage changes and deals.
- Founded BioPhero is founded.
- Funding First funding round of $2.4M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $17.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biophero
Complete news archive for BioPhero
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioPhero
BioPhero was founded in 2018.
BioPhero is headquartered in Copenhagen, Denmark.
Kristian Ebbensgaard is the CEO of BioPhero, as recorded in our data.
BioPhero is a funded company, having raised a total of $21.75M across 6 funding rounds to date. The company's 1st funding round was a Grant of $2.43M, raised on Jan 2018.
BioPhero has 14 employees.
BioPhero was established in 2018 in Copenhagen, Denmark. Insect pheromones are manufactured via a fermentation process involving yeasts, targeting pest control in agriculture. Solutions are provided for specialty crops including apples and grapes. Operations focus on the biotechnology sector, with headquarters located in Lyngby, supporting sustainable pest management practices across Europe.
BioPhero has 6 investors. Key investors include European Union, DCVC, Novo Holdings, FMC Ventures, and Syngenta Group.
The valuation of BioPhero is $21.4M as of Feb 2021.
BioPhero operates through Biophero Aps.